Physarum polycephalum 14-3-3 protein monoclonal antibodies and preparation method thereof
A monoclonal antibody and protein technology, applied in the field of immunology, can solve problems that have not been seen yet, and achieve good results for commercial use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Embodiment 1: Related experimental techniques, reagents and biological materials involved in the present invention
[0050] 1. Cultivation of Physarum polycephalum and preparation of bacteria crushing solution:
[0051] Liquid culture of Chrysomyces polycereus: Chorpheomyces polycereus M3CVII strain (ATCC No. 204388) was donated by Professor Eggehard Holler, Institute of Biophysics, University of Regensburg, Germany. Add 25ml MSD-A solution (3.54g Citric acid, 0.06g FeCl 2 4H 2 O, 0.2g KH 2 PO 4 , 0.6g MgSO 4 ·7H 2 O, 0.084g MnCl 2 4H 2 O, 0.04g ZnSO 4 ·7H 2 O, 0.6g CaCl 2 2H 2 O, 10g Tryptone, 1.5g Yeastextract, 10g Glucose, adjust the pH to 4.6 with 30% KOH, distill the volume to 1L with distilled water, store at room temperature after autoclaving. Solid MSD containing 2% agar powder) and 0.25ml MSD-B solution (0.05g Hematin dissolved in 100ml 1% NaOH solution, stored at 4°C after autoclaving), insert appropriate amount of bacteria, 300rpm, dark culture at...
Embodiment 2
[0074] Example 2: Screening of antigenic determinant peptides and expression and purification of antigenic determinant peptide fusion proteins
[0075] The hydrophilicity, surface accessibility and antigenic index of the P14-3-3 amino acid sequence (its coding sequence GenBank registration number is EF140724) were analyzed with DNAStar biological software. Greater than zero, surface accessibility greater than 1) Select peptides that meet the requirements of the epitope, a total of 1-MTHDESREDS-10, 18-EQAERYDEMV-27, 28-EAMKRVAKLD-37, 35-ENSLIAYKSA-44, 70-EQKEENKGNE were selected -79, 109-QHLIVSSTTG-118, 237-DMQAGGDEPK-246 and 245-PKPVEDEAPA-254 and other 8 potential epitope peptides, and with the assistance of Abmart Shanghai Branch, the company's unique SEAL (Surface Epitope Antibody Library) technology expressed and purified these potential antigenic determinant peptides in Escherichia coli.
Embodiment 3
[0076] Example 3: Immune antigen (completed with the assistance of Abmart Shanghai Branch)
[0077] Take the purified P14-3-3 epitope polypeptide fusion protein solution and mix it with equal amounts of protein, dilute it with PBS solution to a protein mixture solution with a final concentration of 100 μg / ml, take the protein solution and mix it with an equal amount of Freund’s complete adjuvant After emulsification, 8-12-week-old female BALB / c mice were subcutaneously injected into the back at multiple points, and the immunization dose was 40 μg / mouse. After 2 weeks, the antigen solution was emulsified with the same amount of Freund's incomplete adjuvant for the second routine immunization; after another 3 weeks, the third routine immunization was carried out; after another 3 weeks, blood was collected from the tail of the mice, and indirect The antibody titer produced by the mice was detected by ELISA; one month later (the 3rd day before fusion), the mixed antigenic determin...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com